These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
235 related items for PubMed ID: 31509246
1. Tolerogenic dendritic cell transfer ameliorates systemic lupus erythematosus in mice. Funes SC, Ríos M, Gómez-Santander F, Fernández-Fierro A, Altamirano-Lagos MJ, Rivera-Perez D, Pulgar-Sepúlveda R, Jara EL, Rebolledo-Zelada D, Villarroel A, Roa JC, Mackern-Oberti JP, Kalergis AM. Immunology; 2019 Dec; 158(4):322-339. PubMed ID: 31509246 [Abstract] [Full Text] [Related]
2. Autologous tolerogenic dendritic cells derived from monocytes of systemic lupus erythematosus patients and healthy donors show a stable and immunosuppressive phenotype. Obreque J, Vega F, Torres A, Cuitino L, Mackern-Oberti JP, Viviani P, Kalergis A, Llanos C. Immunology; 2017 Dec; 152(4):648-659. PubMed ID: 28763099 [Abstract] [Full Text] [Related]
3. Rel B-modified dendritic cells possess tolerogenic phenotype and functions on lupus splenic lymphocytes in vitro. Wu H, Lo Y, Chan A, Law KS, Mok MY. Immunology; 2016 Sep; 149(1):48-61. PubMed ID: 27278094 [Abstract] [Full Text] [Related]
4. Deficient leptin signaling ameliorates systemic lupus erythematosus lesions in MRL/Mp-Fas lpr mice. Fujita Y, Fujii T, Mimori T, Sato T, Nakamura T, Iwao H, Nakajima A, Miki M, Sakai T, Kawanami T, Tanaka M, Masaki Y, Fukushima T, Okazaki T, Umehara H. J Immunol; 2014 Feb 01; 192(3):979-84. PubMed ID: 24391210 [Abstract] [Full Text] [Related]
6. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway. Dang WZ, Li H, Jiang B, Nandakumar KS, Liu KF, Liu LX, Yu XC, Tan HJ, Zhou C. Phytomedicine; 2019 Sep 01; 62():152965. PubMed ID: 31129432 [Abstract] [Full Text] [Related]
9. Effect of nonmyeloablative unrelated fetal and neonatal murine peripheral blood mononuclear cell infusion on MRL/lpr mice. Chuan W, Wu-qing W, Zhu-wen Y, Zuo L. Lupus; 2014 Sep 01; 23(10):994-1005. PubMed ID: 24756437 [Abstract] [Full Text] [Related]
10. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus. Okazaki H, Hirata D, Kamimura T, Sato H, Iwamoto M, Yoshio T, Masuyama J, Fujimura A, Kobayashi E, Kano S, Minota S. J Rheumatol; 2002 Apr 01; 29(4):707-16. PubMed ID: 11950011 [Abstract] [Full Text] [Related]
11. Sh3bp2 Gain-Of-Function Mutation Ameliorates Lupus Phenotypes in B6.MRL-Faslpr Mice. Nagasu A, Mukai T, Iseki M, Kawahara K, Tsuji S, Nagasu H, Ueki Y, Ishihara K, Kashihara N, Morita Y. Cells; 2019 Apr 30; 8(5):. PubMed ID: 31052273 [Abstract] [Full Text] [Related]
12. Lactobacillus acidophilus Supplementation Exerts a Synergistic Effect on Tacrolimus Efficacy by Modulating Th17/Treg Balance in Lupus-Prone Mice via the SIGNR3 Pathway. Kim DS, Park Y, Choi JW, Park SH, Cho ML, Kwok SK. Front Immunol; 2021 Apr 30; 12():696074. PubMed ID: 34956169 [Abstract] [Full Text] [Related]
13. Regulatory IFN-γ-producing killer dendritic cells are enhanced in B6.MLR-Faslpr /J lupus-prone mice. Rodríguez-Alba JC, Girón-Pérez DA, Romero-Ramírez H, Pelayo R, Santos-Argumedo L. Eur J Immunol; 2018 Nov 30; 48(11):1851-1860. PubMed ID: 30289564 [Abstract] [Full Text] [Related]
14. Heat shock protein 90 inhibition by 17-DMAG lessens disease in the MRL/lpr mouse model of systemic lupus erythematosus. Shimp SK, Chafin CB, Regna NL, Hammond SE, Read MA, Caudell DL, Rylander M, Reilly CM. Cell Mol Immunol; 2012 May 30; 9(3):255-66. PubMed ID: 22543833 [Abstract] [Full Text] [Related]
15. Tolerogenic dendritic cells: role and therapeutic implications in systemic lupus erythematosus. Mok MY. Int J Rheum Dis; 2015 Feb 30; 18(2):250-9. PubMed ID: 25639676 [Abstract] [Full Text] [Related]
16. Tolerogenic Dendritic Cells from Poorly Compensated Type 1 Diabetes Patients Have Decreased Ability To Induce Stable Antigen-Specific T Cell Hyporesponsiveness and Generation of Suppressive Regulatory T Cells. Dáňová K, Grohová A, Strnadová P, Funda DP, Šumník Z, Lebl J, Cinek O, Průhová Š, Koloušková S, Obermannová B, Petruželková L, Šedivá A, Fundová P, Buschard K, Špíšek R, Palová-Jelínková L. J Immunol; 2017 Jan 15; 198(2):729-740. PubMed ID: 27927966 [Abstract] [Full Text] [Related]
17. Therapeutic effect of human amniotic epithelial cells in murine models of Hashimoto's thyroiditis and Systemic lupus erythematosus. Tan B, Yuan W, Li J, Yang P, Ge Z, Liu J, Qiu C, Zhu X, Qiu C, Lai D, Guo L, Wang L, Yu L. Cytotherapy; 2018 Oct 15; 20(10):1247-1258. PubMed ID: 30174233 [Abstract] [Full Text] [Related]
18. Toll-like receptor 7 agonist imiquimod prevents the progression of SLE in MRL/lpr mice via inhibiting the differentiation of T follicular helper cells. Duan X, Shen C, Zhang X, Wu L, Chen J, Ma B, Wang Q, Sun P, Lan Y, Su C. Int Immunopharmacol; 2020 Mar 15; 80():106239. PubMed ID: 32007709 [Abstract] [Full Text] [Related]
19. Immunological mechanisms and clinical implications of regulatory T cell deficiency in a systemic autoimmune disorder: roles of IL-2 versus IL-15. Yang CH, Tian L, Ling GS, Trendell-Smith NJ, Ma L, Lo CK, Stott DI, Liew FY, Huang FP. Eur J Immunol; 2008 Jun 15; 38(6):1664-76. PubMed ID: 18465774 [Abstract] [Full Text] [Related]
20. PDTC attenuate LPS-induced kidney injury in systemic lupus erythematosus-prone MRL/lpr mice. Zhai JX, Zhang ZX, Feng YJ, Ding SS, Wang XH, Zou LW, Ye DQ. Mol Biol Rep; 2012 Jun 15; 39(6):6763-71. PubMed ID: 22318546 [Abstract] [Full Text] [Related] Page: [Next] [New Search]